CN101896595B - Bactericidal cleanser composition - Google Patents
Bactericidal cleanser composition Download PDFInfo
- Publication number
- CN101896595B CN101896595B CN2008801212823A CN200880121282A CN101896595B CN 101896595 B CN101896595 B CN 101896595B CN 2008801212823 A CN2008801212823 A CN 2008801212823A CN 200880121282 A CN200880121282 A CN 200880121282A CN 101896595 B CN101896595 B CN 101896595B
- Authority
- CN
- China
- Prior art keywords
- quality
- cleanser composition
- foam
- bactericidal
- bactericidal cleanser
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D1/00—Detergent compositions based essentially on surface-active compounds; Use of these compounds as a detergent
- C11D1/66—Non-ionic compounds
- C11D1/72—Ethers of polyoxyalkylene glycols
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N25/00—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests
- A01N25/30—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests characterised by the surfactants
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N31/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic oxygen or sulfur compounds
- A01N31/02—Acyclic compounds
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N33/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic nitrogen compounds
- A01N33/02—Amines; Quaternary ammonium compounds
- A01N33/12—Quaternary ammonium compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/14—Quaternary ammonium compounds, e.g. edrophonium, choline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4425—Pyridinium derivatives, e.g. pralidoxime, pyridostigmine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/04—Dispersions; Emulsions
- A61K8/046—Aerosols; Foams
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/39—Derivatives containing from 2 to 10 oxyalkylene groups
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/41—Amines
- A61K8/416—Quaternary ammonium compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
- A61K8/4926—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having six membered rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
- A61K8/922—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/02—Local antiseptics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/005—Antimicrobial preparations
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D1/00—Detergent compositions based essentially on surface-active compounds; Use of these compounds as a detergent
- C11D1/38—Cationic compounds
- C11D1/62—Quaternary ammonium compounds
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
- C11D3/16—Organic compounds
- C11D3/20—Organic compounds containing oxygen
- C11D3/2003—Alcohols; Phenols
- C11D3/2006—Monohydric alcohols
- C11D3/201—Monohydric alcohols linear
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
- C11D3/16—Organic compounds
- C11D3/26—Organic compounds containing nitrogen
- C11D3/33—Amino carboxylic acids
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
- C11D3/48—Medical, disinfecting agents, disinfecting, antibacterial, germicidal or antimicrobial compositions
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Wood Science & Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Birds (AREA)
- Organic Chemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Environmental Sciences (AREA)
- Plant Pathology (AREA)
- Pest Control & Pesticides (AREA)
- Agronomy & Crop Science (AREA)
- Emergency Medicine (AREA)
- Zoology (AREA)
- Dentistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Dermatology (AREA)
- Dispersion Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Toxicology (AREA)
- Detergent Compositions (AREA)
- Cosmetics (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
A bactericidal cleanser composition of the non-wash-off type is characterized by comprising (A) 0.01-1 wt.% of a cationic bactericide selected from benzalkonium chloride, benzyl ammonium chloride or cetylpyridinium chloride , (B-1) 0.01-1.0 wt.% of a nonionic surfactant selected from among polyoxyethylene-hardened castor oil having an HLB of 9 to 16, polyoxyethylene glycerol monostearate and polyethylene glycol monostearate, (C) 0.01-5 wt.% of an amino acid, its salt or dl-sodium pyrrolidonecarboxylate; and (D) 16 to 40 wt.% of an alcohol having 1 to 3 carbon atoms, and being filled in a foamer container and discharged as a foam.
Description
Technical field
The present invention relates to non-wash type bactericidal cleanser composition with the foam state use.
Background technology
No. 3499882 communique of Japanese Patent) or spray form sterilant clean-out system main flow in the past is a wash type, and being difficult to does not have the place of water to use go out or living room etc., and its formulation is that gel is (with reference to patent documentation 1:.But, thereby gelatinous sterilizing agent is because there is the problem on the usabilities such as using the residual viscous sense in back in the tackifier that add, and there is the problem of usability such as disperse above bed etc. in the sterilizing agent of spray form.On the other hand; Though someone proposes sterilizing detergent for cleaning is processed foamy technology (with reference to patent documentation 2: japanese patent laid-open 10-330799 communique, patent documentation 3: Japanese Patent Laid is opened 2001-139993 communique, patent documentation 4: Japanese Patent Laid is opened clear 62-135410 communique), exist and do slowly, be coated with out the problem that the back also has the residual or foam conformality difference of foam on hand.Based on this; People expectation: have the foam conformality when being fetched on hand, be difficult for that drippage falls from hand, after being coated with out on hand, in the time of appropriateness froth breaking, do not have the non-wash type bactericidal cleanser composition that foam is residual and do soon, use with foam state.
Patent documentation 1: No. 3499882 communique of Japanese Patent
Patent documentation 2: japanese patent laid-open 10-330799 communique
Patent documentation 3: Japanese Patent Laid is opened the 2001-139993 communique
Patent documentation 4: Japanese Patent Laid is opened clear 62-135410 communique
Summary of the invention
The present invention In view of the foregoing, purpose is to provide: have the foam conformality when being fetched on hand, be difficult for that drippage falls from hand, after being coated with out on hand, froth breaking in the time of appropriateness, do not have foam residual, and do non-wash type bactericidal cleanser composition soon.
The invention people attentively endeavours research for achieving the above object; The result finds: through specific nonionic surfactant and amino acid or its salt of combination in the bactericidal cleanser composition that contains the cationic sterilant; Even cooperated the alcohol of carbonatoms 1～3; Also can obtain having and have the foam conformality when getting on hand, be difficult for the character that drippage falls from hand, on the other hand, after being coated with out on hand; Froth breaking in the time of appropriateness, do not have foam residual and dried non-wash type bactericidal cleanser composition soon, and accomplished the present invention.Drippage difficulty when getting on hand from hand is relevant with the foamy conformality, and conformality is good more difficultly more when getting on hand to drip from hand, good on the usability.On the other hand, the foam after getting in the hand is vanished to become in the time of appropriateness and had mobile liquid, thereby is easy to be rubbed into finger, and is good on the usability.Can bring into play special action effect through processing formation of the present invention, this is difficult to predict from prior art, is the inventor's newly discovered.
Therefore, the present invention provides following bactericidal cleanser composition.
[1] a kind of non-wash type bactericidal cleanser composition is characterized in that, contains:
(A) be selected from chlorination benzalkonium, zephiran chloride ammonium or TMBEA cationic sterilant 0.01～1 quality %,
(B-1) be selected from HLB9～16 of T 46155 sclerosis Semen Ricini oil, Stearinsaeure T 46155 glycerine ester and Stearinsaeure macrogol ester nonionic surfactant 0.01～1.0 quality %,
(C) amino acid, its salt or dl-pyrrolidone sodium carboxylate 0.01～5 quality % and
(D) alcohol 16～40 quality % of carbonatoms 1～3,
Foam spues after packing in the bubbling container.
[2] a kind of non-wash type bactericidal cleanser composition is characterized in that, contains:
(A) be selected from chlorination benzalkonium, zephiran chloride ammonium or TMBEA cationic sterilant 0.01～1 quality %,
(B-2) be selected from HLB10～14 of polyoxyethylene branched chain alkyl oxide shown in the formula (1) and T 46155 cholesterol ether nonionic surfactant 0.01～1.0 quality %,
[changing 1]
In the formula, m representes that 6～10 integer, n represent 10～25 integer,
(C) amino acid, its salt or dl-pyrrolidone sodium carboxylate 0.01～5 quality % and
(D) alcohol 30～70 quality % of carbonatoms 1～3,
Foam spues after packing in the bubbling container.
The invention effect
According to the present invention; Can provide: have the foam conformality when being fetched on hand, be difficult for that drippage falls from hand, after being coated with out on hand, froth breaking in the time of appropriateness, do not have foam residual; And do soon, with the non-wash type bactericidal cleanser composition of foam state use.
Embodiment
Below, the present invention is detailed.
The 1st bactericidal cleanser composition of the present invention is non-wash type bactericidal cleanser composition; It is characterized in that; Contain nonionic surfactant, (C) amino acid, its salt or dl-pyrrolidone sodium carboxylate and (D) alcohol 16～40 quality % of carbonatoms 1～3 that (A) cationic sterilant, (B-1) are selected from HLB9～16 of T 46155 sclerosis Semen Ricini oil, Stearinsaeure T 46155 glycerine ester and Stearinsaeure macrogol ester; Foam spues after packing in the bubbling container; The 2nd bactericidal cleanser composition is non-wash type bactericidal cleanser composition; It is characterized in that; Contain (A) cationic sterilant, (B-2) and be selected from nonionic surfactant, (C) amino acid, its salt or the dl-pyrrolidone sodium carboxylate of HLB10～14 of polyoxyethylene branched chain alkyl oxide shown in the general formula (1) and T 46155 cholesterol ether and (D) alcohol 30～70 quality % of carbonatoms 1～3, foam spues after in the bubbling container of packing into.
(A) cationic sterilant
The cationic sterilant compound shown in formula (2) or (3) of can giving an example can use a kind or and with more than 2 kinds separately.
[changing 2]
[in the formula, R
1And R
2Represent alkyl, the alkenyl of carbonatoms 8～18 separately or have the alkyl of ehter bond, X and Y represent halogen atom, amino acid or lipid acid separately.]
Compound shown in the general formula (2) can give an example chlorination benzalkonium, zephiran chloride ammonium etc., the compound shown in the general formula (3) TMBEA etc. of can giving an example.Wherein, from the viewpoint of foamy conformality, preferred chlorination benzalkonium, TMBEA.
(A) use level of composition (and with time more than 2 kinds refer to the total amount) preferred 0.01～1 quality %, more preferably 0.01～0.5 quality % in bactericidal cleanser composition.Less than 0.01 quality % has the inadequate worry of bactericidal property, cooperates to surpass 1 quality %, and also be excess quantity from bactericidal property, or it is residual to worry the back foam of rubbing hands.
(B-1) be selected from the nonionic surfactant of HLB9～16 of T 46155 sclerosis Semen Ricini oil, Stearinsaeure T 46155 glycerine ester and Stearinsaeure macrogol ester
The T 46155 sclerosis Semen Ricini oil of HLB9～16 (below, sometimes T 46155 slightly is designated as POE.) can give an example T 46155 (20) sclerosis Semen Ricini oil (HLB9), T 46155 (30) sclerosis Semen Ricini oil (HLB11), T 46155 (40) sclerosis Semen Ricini oil (HLB12), T 46155 (50) sclerosis Semen Ricini oil (HLB13), T 46155 (60) sclerosis Semen Ricini oil (HLB14), T 46155 (80) sclerosis Semen Ricini oil (HLB15), T 46155 (100) sclerosis Semen Ricini oil (HLB15).
The Stearinsaeure T 46155 glycerine ester of HLB9～16 can give an example Stearinsaeure T 46155 (5) glycerine ester (below, be expressed as Triple Pressed Stearic Acid PEG-5 glycerine ester (HLB9).), Triple Pressed Stearic Acid PEG-10 glycerine ester (HLB11), Triple Pressed Stearic Acid PEG-15 glycerine ester (HLB13), Triple Pressed Stearic Acid PEG-20 glycerine ester (HLB14), Triple Pressed Stearic Acid PEG-30 glycerine ester (HLB15), Triple Pressed Stearic Acid PEG-40 glycerine ester (HLB16) etc.
The Stearinsaeure macrogol ester of HLB9～16 can give an example polyoxyethylene glycol (10) monostearate (below, be expressed as Triple Pressed Stearic Acid PEG-10 (HLB11).), Triple Pressed Stearic Acid PEG-20 (HLB14), Triple Pressed Stearic Acid PEG-30 (HLB15), Triple Pressed Stearic Acid PEG-40 (HLB16).
The above-mentioned nonionic surfactant of HLB9 of the present invention～16 can use more than 2 kinds in a kind of independent or suitable combination.Wherein, The T 46155 sclerosis Semen Ricini oil of preferred HLB12～15, Stearinsaeure T 46155 glycerine ester, Stearinsaeure macrogol ester; Can give an example T 46155 (40) sclerosis Semen Ricini oil (HLB12), T 46155 (50) sclerosis Semen Ricini oil (HLB13), T 46155 (60) sclerosis Semen Ricini oil (HLB14), T 46155 (80) sclerosis Semen Ricini oil (HLB15), T 46155 (100) sclerosis Semen Ricini oil (HLB15), Triple Pressed Stearic Acid PEG-15 glycerine ester (HLB13), Triple Pressed Stearic Acid PEG-20 glycerine ester (HLB14), Triple Pressed Stearic Acid PEG-30 glycerine ester (HLB15), Triple Pressed Stearic Acid PEG-20 (HLB14), Triple Pressed Stearic Acid PEG-30 (HLB15).(B-1) nonionic surfactant, not enough HLB9, surpasses HLB16 at foamy conformality variation, and the foamy conformality also can variation sometimes.
(B-2) be selected from the nonionic surfactant of HLB10～14 of polyoxyethylene branched chain alkyl oxide shown in the formula (1) and T 46155 cholesterol ether
[changing 3]
(in the formula, m representes that 6～10 integer, n represent 10～25 integer.)
Polyoxyethylene branched chain alkyl oxide shown in the general formula (1) can be given an example following.
M=6, n=10: T 46155 (10) isocetyl ether (HLB11)
M=6, n=15: T 46155 (15) isocetyl ether (HLB13)
M=6, n=20: T 46155 (20) isocetyl ether (HLB14)
M=7, n=10: T 46155 (10) isooctadecane base ether (HLB11)
M=7, n=15: T 46155 (15) isooctadecane base ether (HLB12)
M=7, n=20: T 46155 (20) isooctadecane base ether (HLB13)
M=7, n=25: T 46155 (25) isooctadecane base ether (HLB14)
M=8, n=10: T 46155 (10) octyl group lauryl ether (HLB10)
M=8, n=16: T 46155 (16) octyl group lauryl ether (HLB12)
M=8, n=20: T 46155 (20) octyl group lauryl ether (HLB13)
M=8, n=25: T 46155 (25) octyl group lauryl ether (HLB14)
M=10, n=15: T 46155 (15) decyl myristyl ether (HLB11)
M=10, n=20: T 46155 (20) decyl myristyl ether (HLB12)
M=10, n=25: T 46155 (25) decyl myristyl ether (HLB13)
Wherein, From the preferred HLB10 of the viewpoint of foamy conformality～13; Particularly, T 46155 (10) octyl group lauryl ether (HLB10), T 46155 (16) octyl group lauryl ether (HLB12), T 46155 (20) octyl group lauryl ether (HLB13), T 46155 (15) decyl myristyl ether (HLB11), T 46155 (20) decyl myristyl ether (HLB12), T 46155 (25) decyl myristyl ether (HLB13).(B-2) nonionic surfactant, not enough HLB10, surpasses HLB14 at foamy conformality variation, and the foamy conformality also can variation sometimes.
T 46155 cholesterol ether can give an example T 46155 (10) cholesterol ether (HLB10), T 46155 (15) cholesterol ether (HLB11), T 46155 (20) cholesterol ether (HLB12), T 46155 (24) cholesterol ether (HLB13), T 46155 (30) cholesterol ether (HLB14) etc.; Wherein, especially preferred T 46155 (10) cholesterol ether (HLB10), T 46155 (15) cholesterol ether (HLB11), T 46155 (20) cholesterol ether (HLB12).The average addition mole number of the numeral oxygen ethene in ().
The HLB value is the value of the intensity balance of the expression hydrophilic group and the hydrophobic group that constitute tensio-active agent, and the method for calculating is according to the formula on the following river.
HLB value=7+11.7log (M
W/ M
O)
M
W: the molecular weight of tensio-active agent hydrophilic segment
M
O: the molecular weight of tensio-active agent oleophilic moiety
(B-1) and (B-2) use level of composition when using more than 2 kinds (and be total amount) preferred 0.01～1.0 quality % in bactericidal cleanser composition is from more preferably 0.1～0.5 quality % of the not residual viewpoint of foamy conformality, the back foam of rubbing hands.Less than 0.01 quality %, the inadequate worry of frothy conformality surpasses 1.0 quality %, and the worry of using back generation viscous sense or rubbing hands the not residual situation variation of back foam is arranged.
(C) amino acid, its salt or dl-pyrrolidone sodium carboxylate
Can give an example glycocoll, Methionin, Serine, proline(Pro), l-arginine, L-glutamic acid etc. and pyrrolidone carboxylic acid's amino acid derivative etc. of amino acid of the present invention, they can use a kind or suitable combination to use more than 2 kinds separately.As salt, can give an example basic metal, alkaline-earth metal etc.Example has, Sodium Glutamate, dl-pyrrolidone sodium carboxylate etc.Wherein, from the viewpoint of foam conformality, preferred dl-pyrrolidone sodium carboxylate, Methionin, Serine, glycocoll, especially preferred dl-pyrrolidone sodium carboxylate.
(C) use level of composition when using more than 2 kinds (and be total amount) preferred 0.01～5 quality %, more preferably 0.1～1 quality % in bactericidal cleanser composition.Less than 0.01 quality % has the worry of getting on hand the situation variation that the back foam is difficult in the time of appropriateness, disappearing, foam is not residual, surpasses 5 quality %, and the inadequate worry of foam conformality when spuing is arranged.
(D) alcohol of carbonatoms 1～3
The alcohol of carbonatoms 1～3 can give an example ethanol, Virahol etc. can use a kind or suitable combination to use more than 2 kinds separately.Wherein, the viewpoint of the smell during use, preferred alcohol.
In the 1st bactericidal cleanser composition of the present invention, (D) use level of composition when using more than 2 kinds (and be total amount) is 16～40 quality % in bactericidal cleanser composition, from the foamy conformality, not residual preferred 20～30 quality % of viewpoint of back foam rub hands.Less than 16 quality % are prone to the dryness variation, again, surpass 40 quality %, even occurring from bubbling container, can not spue blister yet, be difficult for getting on hand or the unfavorable condition that liquid drips from water takes place to become at once.
In the 2nd bactericidal cleanser composition of the present invention; (D) use level of composition when using more than 2 kinds (and be total amount) is 30～70 quality % in bactericidal cleanser composition; From foamy conformality and the not residual viewpoint of back foam of rubbing hands, preferred 30～50 quality %.It is good especially that the above words of 50 quality % are prone to dryness.The words of less than 30 quality %; Thereby even if can not be in the time of appropriateness after occurring rubbing hands the residual situation of froth breaking foam; In addition; Surpass 70 quality %,, be difficult for getting on hand or the unfavorable condition that liquid drips from water takes place to become at once even occurring from bubbling container, can not spue blister yet.
In the scope of not damaging effect of the present invention, can cooperate composition arbitrarily in the bactericidal cleanser composition of the present invention.Composition can be given an example arbitrarily, and sugar alcohol, gonorrhoea agent, antioxidant, metals such as the medicament of antiphlogistics such as the solvent of polyvalent alcohol etc., the sterilant of removing (A) composition and (D) composition, water-soluble high-molecular compound, Rizinsan K2 A2, spices, freshener, the agent that cools, colouring matter, oil content, polysiloxane-based, VITAMINs etc., Sorbitol Powder, tetrahydroxybutane block insoluble polymer powder, water etc. such as agent (sequestering agents), plant-animal extract or derivatives thereof, inorganic powder, clay mineral, nylon, Vilaterm.They can a kind use separately or suitable combination is used more than 2 kinds, in the scope of not damaging effect of the present invention, can cooperate in right amount.
Polyvalent alcohol can give an example polyoxyethylene glycol, 1,3 butylene glycol, USP Kosher etc. preferably cooperate 0～5 quality %.Though through cooperating polyvalent alcohol can prevent that skin is coarse, surpass 5 quality % and cooperate, exist and use the back skin to produce the worry of viscous sense.
Remove (A) composition and (D) sterilant of composition can give an example isopropyl methyl phenol, triclosan, TRICLOCARBON, hydrochloric acid chlorhexidine, alkyl diamino ethyl glycocoll, オ Network ト ピ ロ Star Network ス (octopirox; It is trade(brand)name; Composition is an octopirox) etc.
Water-soluble high-molecular compound can be given an example, the amphiphilic polymers of nonionic macromolecular compounds such as the anionic property macromolecular compound of alkyl acrylate copolymer etc., Poise C-80M, chlorination dimethyldiallylammonium acrylamide copolymer, cation-modified guar gum cationic macromolecular compounds such as (guar gum), Vltra tears, vinyl acetate vinylpyrrolidone copolymer, dimethyl propylene thiazolinyl quaternary salt acrylic acid acrylamide vinyl pyrrolidone NN-dimethyl aminoethyl etc. etc.
Spices can use the flavor compositions that is made up of with solvent and spices stabilization agent fragrance component, spices, and the content of flavor compositions is preferred 0.005～40 quality %, more preferably 0.01～10 quality % in bactericidal cleanser composition.Be used as the inventory of the perfume base of fragrance component, can exemplify various documents, for example, " Perfume and Flavor Chemicals ", Vol.I and II, Steffen Arctander, Allured publishing company. (1994); " synthetic perfume chemistry と knowledge of goods ", seal rattan unit one work, chemical industry day newspaper office (1996); " Perfume and Flavor Materials of Natural Origin ", Steffen Arctander, Allured publishing company. (1994); " fragrant り encyclopaedia ", Japanese fragrance association are compiled, the bookstore (1989) towards the storehouse; " Perfumery Material Performance is V.3.3 ", Boelens Aroma chemical information service company (1996); " Flower oils and Floral Compounds In Perfumery ", Danute Lajaujis Anonis, Allured publishing company. (1993) etc. for example, can suit to select above-mentioned fragrance component from the perfume base of these document records.Particularly, for example, Oil of Eucalyptus, camphor, borneol, PH 6968, white lemon oil, grapefruit extract, Oleum lavandula angustifolia, Herba Lysimachiae foenumgraeci extract, rosemary oil, rosemary extract etc.
Spices can be given an example with solvent; Ethanol, peruscabin, acetin (triactin), MMB acetic ester (3-methoxyl group-3-methylbutyl acetic ester), two butyric acid glycol esters, pinakon, Uniflex DBS, Deltyl Extra (Isopropyl myristate), methyl carbitol (diethylene glycol monomethyl ether), Trivalin SF (TC), TEG (triethylene glycol), TRIMETHOXY BENZOIC ACID (FOR MANUFACTURING OF T.M. benzyl ester, Ucar 35, diethyl phthalate, tripropylene glycol, avolin (dimethyl phthalate), Deltyl Prime (Wickenol 111), dipropylene glycol DPG-FC (dipropylene glycol), farnesene (farnesene), hexanodioic acid dioctyl ester, tributyrin (three butyric acid glycerine esters), siliceous sinter-5 (1; The 2-pentanediol), propylene glycol diacetate, acetate cetyl ester (hexadecyl acetic ester), ethyl abietate, abalyn (abalyn) (methyl abietate), Citroflex A-2 (citric acid acetyl three ethyl ester), Citoflex A-4 (Hydrocerol A tributyl acetonyl ester), Citoflex No.2 (Hydrocerol A triethyl ester), Citoflex No.4 (Hydrocerol A tributyl ester), Dorafix (dihydro methyl abietate), MITD (tetradecanoic acid different three last of the ten Heavenly stems ester), gather PC 560 (PC 560 polymkeric substance), 1,3 butylene glycol etc.Spices is with content preferred 0.1～99 quality %, more preferably 0.1～10 quality % in flavor compositions of solvent.
Spices stabilization agent can give an example butylated hydroxytoluene, butylated hydroxy anisole, vitamin E and verivate thereof, catechin compounds, flavonoid compound, polyphenolic substance etc., wherein, preferred butylated hydroxytoluene.The content of spices stabilization agent is preferred 0.0001～10 quality % in flavor compositions, more preferably 0.001～5 quality %.
Freshener can exemplify menthol, green pepper peppermint oil, peppermint wet goods.Particularly, can give an example the N-ethyl to the menthane carboxamide (trade(brand)name: WS3), 1-menthyl USP Kosher ether (trade(brand)name: CA-10), lactic acid menthyl ester (trade(brand)name: FrescolatML, FrescolatMGA) etc.
As the method for manufacture of bactericidal cleanser composition of the present invention, if mixed above-mentioned must composition, composition, He Shui (remnants of defeated troops) arbitrarily, not special the qualification can be according to the suitable selection of purpose.In addition, the device of preparation bactericidal cleanser composition is not special yet to be limited, and can select according to purpose is suitable, preferably has shear strength and all whipping apptss of a plurality of agitating vanes of blended (water screw, turbine, dispersible tablet etc.).The raw material of bactericidal cleanser composition is not special to be limited, and can select according to purpose is suitable.In addition, can use each raw material also can use the mixture that contains each raw material separately.
The pH of bactericidal cleanser composition of the present invention preferred 4～7.From the preferred above-mentioned scope of the viewpoint of skin mildness, surpass pH7, the worry of efficiency of preservation variation is arranged.Hydrocerol A and Trisodium Citrate are preferably used in the adjustment of pH.PH of the present invention is under 25 ℃, the value of using pH meter (East Asia electric wave industry system HM-30G), pH electrode (East Asia デ イ one ケ one ケ one (strain) system GST-5721C type) to measure.
Bactericidal cleanser composition of the present invention is liquid at normal temperatures, below the preferred 30mPas of viscosity of the following bactericidal cleanser composition of temperature condition that uses, more preferably below the 10mPas.Viscosity of the present invention be under the temperature (use temperature condition, common 25 ℃), use the value of measuring in 60 seconds under rotational viscosimeter (Tokyo gauge (strain) system, pattern B8L), the No.1 rotor speed 60rpm.
Bactericidal cleanser composition of the present invention is the non-wash type of foamy that spues after packing in the bubbling container.Owing to be blister, use than the easier of gel or spray form, can carry out sterilization in the place that does not have water simply and clean.In addition, also can process and have non-wash type bactericidal cleanser composition and wherein and make the sterilizing detergent for cleaning goods of its bubbling container that spues with blister its income.
Bubbling container the telling the bubble container, using the aerosol container of propellant and pressure vessel of non-pneumatic type of can giving an example, preferred non-pneumatic type tell the bubble container.The non-pneumatic type tell the bubble container so long as can then not have special qualification with bactericidal cleanser composition and air mixed and with the container that foamed state spues; For example; Through the foamy extruding bubbling container that spues with hand squeeze bottle body, through pressing the spray nozzle part foamy pump bubbling container etc. that can spue, can select according to purpose is suitable.Such bubbling container can use the bubbling container of Daiwa Can Co.'s system, Yoshino Kogyosho Co., Ltd's system etc.More specifically, bubbling container bubbling container that can use japanese patent laid-open 7-315463 communique, japanese patent laid-open 8-230961 communique and Japanese Patent Laid to open to put down in writing in the 2005-193972 communique etc.
The bubble container of telling of non-pneumatic type has bubble formation parts, particularly, has the porous film body (plastic materials of the preferred nylon of material, polyester, polyolefine etc.) that is used to form bubble, forms bubble through making bactericidal cleanser composition pass through this porous film body.The mesh of porous film body is not special to be limited, and can select according to purpose is suitable, and for example, preferred 100 orders are above, more preferably 100～400 orders, preferred especially 200～305 orders.In addition, the number of porous film body is not special to be limited, and can select according to purpose is suitable, from preferred 2～4 of the viewpoint that improves the bubble performance.More specifically, can use japanese patent laid-open 7-315463 communique, japanese patent laid-open 8-230961 communique, Japanese Patent Laid to open the bubbling container of putting down in writing in the 2005-193972 communique.For example, use when pushing each 1 in pump bubbling container and 305,200 orders that spray nozzle part can Tu Pao, below the preferred 30mPas of viscosity of bactericidal cleanser composition under the temperature condition that uses, more preferably below the 10mPas.
Among the present invention, non-wash type is meant: the bactericidal cleanser composition of blister is placed hand, be coated with out at the sterilization cleaning object for example behind the skin of hand, whole body etc., need not cleanings such as water and use.Method of use is not special to be limited, and for example, 1 repeatedly, gets an amount of 1～15g with blister and place hand, is scattered in sterilization cleaning object for example hand, whole body etc.
Embodiment
Below, show that embodiment and comparative example detail the present invention, but the present invention is not limited to following embodiment.The short of special instruction of following example, " % " expression quality % of composition, ratio represent that the one-tenth component of mass ratio, embodiment record is that pure branch converts entirely.
[embodiment 1～67, comparative example 1～17]
According to the bactericidal cleanser composition of forming shown in well-established law preparation table 1～14, the pH of compsn is adjusted into about 5.6.Use rotational viscosimeter (Tokyo gauge (strain) system, pattern B8L), No.1 rotor speed 60rpm, measured the viscosity (25 ℃) of the bactericidal cleanser composition of embodiment in 60 seconds, the result is 1～9mPas.The bactericidal cleanser composition 200g that obtains is filled in the bubbling container of 250mL.The operating specification of this bubbling container is opened method, commodity in use name W-5721, the WP.FTL nozzle of putting down in writing in the 2005-193972 communique (lucky wild industry is made) according to Japanese Patent Laid.Particularly, use gas/liquid volume ratio: 13/1, discharge-amount: 1g (1 extruding), bore 5mm * 8mm (ellipticity), foam form parts: each bubbling container of 1 of 200 orders and 305 purpose porous film bodies.
[foamy conformality]
Under the condition of 25 ℃ of 60%RH, on the polyvinylidene chloride film, the spumescence that from bubbling container, spues bactericidal cleanser composition 1g measures the foam height after spuing 30 seconds.In this evaluation method, not enough 5mm's, its foamy conformality is poor, be easy to drippage when placing hand, and 20mm is above, places the foam of hand in the time of appropriateness, not disappear, is difficult to be rubbed into hand.That is, in this evaluation method, as the bubble conformality of usability coideal and the foam time of appropriateness, not enough 20mm's is better more than the 5mm.The result is to be benchmark with the MV measured for 3 times, shows according to following determinating reference.
< determinating reference >
◎: 16mm is above, not enough 20mm
Zero: 13mm is above, not enough 16mm
△: 5mm is above, not enough 13mm
*: not enough 5mm or more than the 20mm
[foam after rubbing hands is not residual]
Under the condition of 25 ℃ of 60%RH, make blister bactericidal cleanser composition 1g from bubbling container, spue in one's hands in, after rubbing hands about 10 seconds, estimate and to remain in the foam in the hand.10 expert groups according to following scoring carry out the sense evaluation, with the MV of this scoring be benchmark, according to following determinating reference display result.
< scoring >
5 minutes: do not have foam residual (in the tolerable limit) fully
4 minutes: do not have foam residual (in the tolerable limit) basically
3 minutes: some foams residual (in the tolerable limit) are arranged slightly
2 minutes: more foam residual (tolerable limit is outer) is arranged
1 minute: foam increased (tolerable limit is outer)
< determinating reference >
◎: more than 4.0
Zero: 3.0 above, less than 4.0
△: more than 2.0, less than 3.0
*: 2.0 deficiencies
[being prone to dryness]
Under the condition of 25 ℃ of 60%RH, make blister bactericidal cleanser composition 1g from bubbling container, spue in one's hands in, while rub the time of liquid till the drying of measuring in one's hands and the nail with the hands.10 expert groups carry out the sense evaluation, according to the MV of time, with following determinating reference display result.
< determinating reference >
◎: less than 30 seconds (in the tolerable limit)
More than zero: 30 second, less than 60 seconds (in the tolerable limit)
△: more than 60 seconds, less than 90 seconds (tolerable limit is outer)
*: more than 90 seconds (tolerable limit is outer)
[sterilizing power (sterilization rate (%)]
3 fingers of a hand are lain in the bacterium of collecting in the standard nutrient agar (Japanese pharmacy (strain) system) before using.Then, the another hand is got bactericidal cleanser composition 1g, rubs hands to refer to become dry until liquid, then 3 fingers is lain in the standard nutrient agar, collects the bacterium (streak plating) after using.The bacterium of the finger that uses the bactericidal cleanser composition front and back after 24 hours, is measured colony count in cultivation under 37 ℃.According to following formula, by the colony count A before using
0, the colony count A after the use
1The expression sterilization rate.Sterilization rate more than 95% be effectively, less than 70% is for invalid.
Sterilization rate (%)=(1-A
1/ A
0) * 100
[table 1]
*1: alkyl chain length (R
1) be C12/C14=63/37 (mass ratio)
*2: alkyl chain length (R
2) be C16
*3: alkyl (R with ehter bond
1) be C
18H
29O
2
[table 2]
*1: alkyl chain length (R
1) be C12/C14=63/37 (mass ratio)
[table 3]
*1: alkyl chain length (R
1) be C12/C14=63/37 (mass ratio)
[table 4]
*1: alkyl chain length (R
1) be C12/C14=63/37 (mass ratio)
[table 5]
*1: alkyl chain length (R
1) be C12/C14=63/37 (mass ratio)
[table 6]
*1: alkyl chain length (R
1) be C12/C14=63/37 (mass ratio)
*2: alkyl chain length (R
2) be C16
[table 7]
*1: alkyl chain length (R
1) be C12/C14=63/37 (mass ratio)
*2: alkyl chain length (R
2) be C16
*3: alkyl (R with ehter bond
1) be C
18H
29O
2
[table 8]
*1: alkyl chain length (R
1) be C12/C14=63/37 (mass ratio)
[table 9]
*1: alkyl chain length (R
1) be C12/C14=63/37 (mass ratio)
*2: alkyl chain length (R
2) be C16
*3: alkyl (R with ehter bond
1) be C
18H
29O
2
[table 10]
*1: alkyl chain length (R
1) be C12/C14=63/37 (mass ratio)
[table 11]
*1: alkyl chain length (R
1) be C12/C14=63/37 (mass ratio)
[table 12]
*1: alkyl chain length (R
1) be C12/C14=63/37 (mass ratio)
[table 13]
*1: alkyl chain length (R
1) be C12/C14=63/37 (mass ratio)
*2: alkyl chain length (R
2) be C16
[table 14]
*1: alkyl chain length (R
1) be C12/C14=63/37 (mass ratio)
[embodiment 68]
According to following composition, use bactericidal cleanser composition according to the whole body of well-established law preparation embodiment 68.The whole body that obtains likewise is filled in the bubbling container with bactericidal cleanser composition and embodiment 1, carries out same evaluation.(pH5.6, viscosity (25 ℃), 4mPas)
[table 15]
*1: alkyl chain length (R
1) be C12/C14=63/37 (mass ratio)
(evaluation result)
Foamy conformality: ◎
Foam after rubbing hands is not residual: ◎
Be prone to dryness: zero
Sterilization rate: 99%
The raw material that uses when preparation embodiment and comparative example is as follows.
(1) chlorination benzalkonium: day oil (strain) system, Nissan Cation F2-50E
*1: alkyl chain length (R
1) be C12/C14=63/37 (mass ratio)
(2) TMBEA: with the pure pharmaceutical worker's industry of light (strain) system, TMBEA
*2: alkyl chain length (R
2) be C16
(3) crystallization of zephiran chloride ammonium: Mitsubishi Chemical's Off one ズ (strain) system quaternary ammonium salt (Ha イ ア ミ Application)
*3: alkyl (R with ehter bond
1) be C
18H
29O
2
(4) T 46155 (20) sclerosis Semen Ricini oil (PEG-20 harden Semen Ricini oil): Japanese エ マ Le ジ ヨ Application (strain) is made, EMALEX HC-20
(5) T 46155 (40) sclerosis Semen Ricini oil (PEG-40 harden Semen Ricini oil): Japanese エ マ Le ヅ ヨ Application (strain) is made, EMALEX HC-40
(6) T 46155 (60) sclerosis Semen Ricini oil (PEG-60 harden Semen Ricini oil): Japanese エ マ Le ヅ ヨ Application (strain) is made, EMALEX HC-60
(7) T 46155 (100) sclerosis Semen Ricini oil (PEG-100 harden Semen Ricini oil): Japanese エ マ Le ヅ ヨ Application (strain) is made, EMALEX HC-100
(8) Triple Pressed Stearic Acid PEG-10: Japanese エ マ Le ジ ヨ Application (strain) system, EMALEX810
(9) Triple Pressed Stearic Acid PEG-20: Japanese エ マ Le ヅ ヨ Application (strain) system, EMALEX820
(10) Triple Pressed Stearic Acid PEG-40: Japanese エ マ Le ヅ ヨ Application (strain) system, EMALEX840
(11) Triple Pressed Stearic Acid PEG-10 glycerine ester: Japanese エ マ Le ヅ ヨ Application (strain) system, EMALEX GM-10
(12) Triple Pressed Stearic Acid PEG-15 glycerine ester: Japanese エ マ Le ヅ ヨ Application (strain) system, EMALEX GM-15
(13) Triple Pressed Stearic Acid PEG-40 glycerine ester: Japanese エ マ Le ヅ ヨ Application (strain) system, EMALEX GM-40
(14) dl-pyrrolidone sodium carboxylate aginomoto (strain) system, PCA ソ one ダ
(15) Methionin: aginomoto (strain) system, L-Lysine mono Hydrochloride
(16) Serine: consonance fermentation industry (strain) system, L-Serine
(17) T 46155 (10) sclerosis Semen Ricini oil (PEG-10 harden Semen Ricini oil): Japanese エ マ Le ジ ヨ Application (strain) is made, EMALEX HC-10
(18) Triple Pressed Stearic Acid PEG-150: Japanese エ マ Le ジ ヨ Application (strain) system, EMALEX 6300M-ST
(19) imidazolinium betaine: eastern nation chemical industry (strain) system, オ バ ゾ リ Application 662N
(20) T 46155 (10) cholesterol ether: Japanese エ マ Le ヅ ヨ Application (strain) system, EMALEX CS-10
(21) T 46155 (15) decyl myristyl ether: Japanese エ マ Le ヅ ヨ Application (strain) system, EMALEX 2415
(22) T 46155 (10) octyl group lauryl ether: Japanese エ マ Le ヅ ヨ Application (strain) system, EMALEX OD-10
(23) T 46155 (20) octyl group lauryl ether: Japanese エ マ Le ヅ ヨ Application (strain) system, EMALEX OD-20
(24) T 46155 (25) octyl group lauryl ether: Japanese エ マ Le ヅ ヨ Application (strain) system, EMALEX OD-25
(25) T 46155 (5) cholesterol ether: Japanese エ マ Le ヅ ヨ Application (strain) system, EMALEX CS-5
(26) T 46155 (10) decyl myristyl ether: Japanese エ マ Le ヅ ヨ Application (strain) system, EMALEX 2410
Claims (2)
1. a non-wash type bactericidal cleanser composition is characterized in that, contains:
(A) be selected from chlorination benzalkonium, zephiran chloride ammonium or TMBEA cationic sterilant 0.01～1 quality %,
(B-1) be selected from HLB9～16 of T 46155 sclerosis Semen Ricini oil, Stearinsaeure T 46155 glycerine ester and Stearinsaeure macrogol ester nonionic surfactant 0.01～1.0 quality %,
(C) amino acid, its salt or dl-pyrrolidone sodium carboxylate 0.01～5 quality % and
(D) alcohol 16～40 quality % of carbonatoms 1～3,
Foam spues after packing in the bubbling container.
2. a non-wash type bactericidal cleanser composition is characterized in that, contains:
(A) be selected from chlorination benzalkonium, zephiran chloride ammonium or TMBEA cationic sterilant 0.01～1 quality %,
(B-2) be selected from HLB10～14 of polyoxyethylene branched chain alkyl oxide shown in the formula (1) and T 46155 cholesterol ether nonionic surfactant 0.01～1.0 quality %,
[changing 1]
In the formula, m representes that 6～10 integer, n represent 10～25 integer,
(C) amino acid, its salt or dl-pyrrolidone sodium carboxylate 0.01～5 quality % and
(D) alcohol 30～70 quality % of carbonatoms 1～3,
Foam spues after packing in the bubbling container.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2007320531 | 2007-12-12 | ||
| JP2007-320531 | 2007-12-12 | ||
| PCT/JP2008/069407 WO2009075142A1 (en) | 2007-12-12 | 2008-10-27 | Bactericidal cleanser composition |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN101896595A CN101896595A (en) | 2010-11-24 |
| CN101896595B true CN101896595B (en) | 2012-04-25 |
Family
ID=40755387
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2008801212823A Active CN101896595B (en) | 2007-12-12 | 2008-10-27 | Bactericidal cleanser composition |
Country Status (6)
| Country | Link |
|---|---|
| JP (1) | JP5343857B2 (en) |
| KR (1) | KR101443951B1 (en) |
| CN (1) | CN101896595B (en) |
| HK (1) | HK1145511A1 (en) |
| MY (1) | MY155282A (en) |
| WO (1) | WO2009075142A1 (en) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE102009029200A1 (en) * | 2009-09-04 | 2011-03-17 | Wacker Chemie Ag | Isocyanate-free silane-crosslinking compositions |
| JP5583385B2 (en) * | 2009-11-04 | 2014-09-03 | 大日本除蟲菊株式会社 | disinfectant |
| JP5700558B2 (en) * | 2011-11-02 | 2015-04-15 | ライオン株式会社 | Sheet cosmetic |
| JP6510177B2 (en) * | 2014-04-01 | 2019-05-08 | ロレアル | Compositions in the form of nano or microemulsions |
| WO2015159942A1 (en) * | 2014-04-17 | 2015-10-22 | 株式会社シード | Medical device including anionic drug |
| JP6537788B2 (en) | 2014-06-25 | 2019-07-03 | ロレアル | Composition in the form of a nanoemulsion or microemulsion or having a lamellar structure |
| CN104974859B (en) * | 2015-06-29 | 2017-12-22 | 陈士友 | Waterless carwash liquid |
| JP6281144B2 (en) * | 2016-06-22 | 2018-02-21 | 石原ケミカル株式会社 | Cleaning composition for car air conditioner and aerosol composition using the same |
| KR102638891B1 (en) * | 2017-12-28 | 2024-02-23 | 라이온 가부시키가이샤 | Non-rinse type liquid sterilizing and cleaning agent composition |
| JP7300139B2 (en) * | 2018-07-18 | 2023-06-29 | 株式会社日本色材工業研究所 | oily cosmetics |
| CN110201603B (en) * | 2019-06-13 | 2021-08-13 | 湖南华腾制药有限公司 | Cationic surfactant and preparation method thereof |
| JP7345886B2 (en) * | 2020-05-25 | 2023-09-19 | 株式会社東洋新薬 | Alcohol-containing composition |
| JP7516327B2 (en) * | 2021-09-02 | 2024-07-16 | 花王株式会社 | Disinfection products |
Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1166959A (en) * | 1996-04-05 | 1997-12-10 | 花王株式会社 | Composition of detergent |
| CN1185480A (en) * | 1996-12-20 | 1998-06-24 | 花王株式会社 | Detergent composition |
| CN1185482A (en) * | 1996-12-20 | 1998-06-24 | 花王株式会社 | Detergent composion |
| JP2001139993A (en) * | 1999-11-17 | 2001-05-22 | Fumakilla Ltd | Disinfection detergent for skin |
| JP2001311092A (en) * | 2000-04-28 | 2001-11-09 | Lion Corp | Bactericidal compound-containing composition |
| JP2003055699A (en) * | 2001-08-20 | 2003-02-26 | Lion Corp | Liquid detergent composition |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH06279268A (en) * | 1993-01-27 | 1994-10-04 | Takeda Chem Ind Ltd | Disinfecting and sterilizing agent and aerosol composition containing the same |
| JPH10330799A (en) * | 1997-06-04 | 1998-12-15 | Lion Corp | Frothy bactericidal detergent composition |
-
2008
- 2008-10-27 JP JP2009545367A patent/JP5343857B2/en active Active
- 2008-10-27 KR KR1020107013334A patent/KR101443951B1/en active IP Right Grant
- 2008-10-27 WO PCT/JP2008/069407 patent/WO2009075142A1/en active Application Filing
- 2008-10-27 MY MYPI2010002588A patent/MY155282A/en unknown
- 2008-10-27 CN CN2008801212823A patent/CN101896595B/en active Active
-
2010
- 2010-12-21 HK HK10111941.5A patent/HK1145511A1/en unknown
Patent Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1166959A (en) * | 1996-04-05 | 1997-12-10 | 花王株式会社 | Composition of detergent |
| CN1185480A (en) * | 1996-12-20 | 1998-06-24 | 花王株式会社 | Detergent composition |
| CN1185482A (en) * | 1996-12-20 | 1998-06-24 | 花王株式会社 | Detergent composion |
| JP2001139993A (en) * | 1999-11-17 | 2001-05-22 | Fumakilla Ltd | Disinfection detergent for skin |
| JP2001311092A (en) * | 2000-04-28 | 2001-11-09 | Lion Corp | Bactericidal compound-containing composition |
| JP2003055699A (en) * | 2001-08-20 | 2003-02-26 | Lion Corp | Liquid detergent composition |
Also Published As
| Publication number | Publication date |
|---|---|
| HK1145511A1 (en) | 2011-04-21 |
| JP5343857B2 (en) | 2013-11-13 |
| KR20100106975A (en) | 2010-10-04 |
| JPWO2009075142A1 (en) | 2011-04-28 |
| KR101443951B1 (en) | 2014-09-23 |
| WO2009075142A1 (en) | 2009-06-18 |
| CN101896595A (en) | 2010-11-24 |
| MY155282A (en) | 2015-09-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101896595B (en) | Bactericidal cleanser composition | |
| US20090324660A1 (en) | Personal-care article for sequentially dispensing compositions with different fragrances | |
| CA2572636C (en) | Personal care compositions with improved hyposensitivity | |
| CN108883039A (en) | The oral care composition shown with effective flavor | |
| CN109069362A (en) | Oral care composition containing potassium nitrate and peroxide | |
| CN107847402A (en) | Oral care composition containing AMPS polymer, copolymer or cross-linked polymer | |
| JP2014009201A (en) | Leave-in bactericidal cleanser composition | |
| JP7245609B2 (en) | external composition | |
| CN109069361A (en) | Oral care composition comprising gel network phase and potassium nitrate | |
| CN109069363A (en) | Oral care composition comprising gel network and potassium nitrate | |
| JP5038860B2 (en) | Liquid detergent composition | |
| CN108883033A (en) | Oral care composition containing gel network phase | |
| US10682383B2 (en) | Personal care compositions with improved hyposensitivity | |
| JP5972052B2 (en) | Gel-like fragrance composition | |
| CN116261443B (en) | Composition for external use for nanobubble cosmetics | |
| JP7155943B2 (en) | Liquid oral compositions and oral spray formulations | |
| JP2007332046A (en) | Hair shampoo | |
| JP6613123B2 (en) | Antiperspirant deodorant composition | |
| KR20130140124A (en) | Liquid or liquefied oral composition and agent for inhibiting adherence of tongue plaque | |
| JP2019094281A (en) | Skin cosmetic | |
| US20240197580A1 (en) | Micellar bi-phase makeup spray in a non-aerosol fine mist packaging | |
| JP7049868B2 (en) | Antiperspirant composition | |
| EP4098326A1 (en) | Unit dose for cosmetic composition comprising an effervescent system | |
| TW201628595A (en) | Composition for external use and use thereof | |
| JP2023085926A (en) | Transparent mist type cosmetic composition |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| REG | Reference to a national code |
Ref country code: HK Ref legal event code: DE Ref document number: 1145511 Country of ref document: HK |
|
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| REG | Reference to a national code |
Ref country code: HK Ref legal event code: GR Ref document number: 1145511 Country of ref document: HK |